FAME Trial


chevron_left Newsroom

Feb. 03, 2020

28% relative reduction in clinical events at 1 year.

The FAME trial compared FFR-guided PCI decision- making (by pressure wire) versus PCI guided by angiography alone in 1,005 randomized patients with multi-vessel coronary artery disease. Routine measurement of FFR significantly reduced clinical events at 1 year.

Learn how the CathWorks FFRangio® System can impact your practice.


    expand_lessBack to top of page

    We use cookies to enhance your experience. By continuing to visit this site, you agree to our use of cookies. Terms and Conditions